Inventor · disambiguated record
Leong Ng
Also filed as: NG LEONG · NG LEONG L · NG LEONG LOKE
6 granted patents·14 pending applications·36 citations·filing 2003–2020
80Inventor score
Top patents by PatentIndex Score
20 records- 0189US9229013B2Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunctionBERGMANN ANDREAS·Filed 2010·Granted Jan 5, 2016·10 cites·17 claims
- 0285US8524463B2Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNPBERGMANN ANDREAS·Filed 2007·Granted Sep 3, 2013·10 cites·20 claims
- 0384US9012151B2Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullinNG LEONG LOKE·Filed 2007·Granted Apr 21, 2015·12 cites·18 claims
- 0478US8501485B2Risk stratification for acute coronary syndrome by determining copeptinBERGMANN ANDREAS·Filed 2007·Granted Aug 6, 2013·4 cites·13 claims
- 0564US2020300868A1Method for predicting the risk of getting a major adverse cardiac eventSPHINGOTEC GMBH·Filed 2020·Application pending·0 cites
- 0662US10254289B2In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patientBRAHMS GMBH·Filed 2016·Granted Apr 9, 2019·0 cites·12 claims
- 0762US9261517B2Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin IIBRAHMS GMBH·Filed 2013·Granted Feb 16, 2016·0 cites·9 claims
- 0862US2020225250A1hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a SubjectSPHINGOTEC GMBH·Filed 2020·Application pending·0 cites
- 0959US2016252526A1A method for predicting the risk of getting a major adverse cardiac eventSPHINGOTEC GMBH·Filed 2014·Application pending·0 cites
- 1053US2015192595A1Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullinBRAHMS GMBH·Filed 2015·Application pending·0 cites
- 1152US2017234889A1hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a SubjectSPHINGOTEC GMBH·Filed 2015·Application pending·0 cites
- 1251US2011229911A1Azurophilic granule proteases as markers in cardiological diseasesBRAHMS GMBH·Filed 2009·Application pending·0 cites
- 1350US2011117589A1Use of procalcitonin (pct) in prognosis following acute coronary syndromesBRAHMS AG·Filed 2009·Application pending·0 cites
- 1443US2005244904A1Diagnostics based on signal peptide detectionNG LEONG·Filed 2004·Application pending·0 cites
- 1542US2005014198A1Assays and kits for detecting and monitoring heart diseaseFiled 2004·Application pending·0 cites
- 1641US2004265926A1Bodily fluid markers of tissue hypoxiaNG LEONG·Filed 2003·Application pending·0 cites
- 1741US2004077027A1Assays and kits for detecting and monitoring heart diseaseNG LEONG·Filed 2003·Application pending·0 cites
- 1839US2009081714A1AssaysINVERNESS MEDICAL SWITZERLAND·Filed 2006·Application pending·0 cites
- 1938US2006155200A1Method for prediction of cardiac diseaseUNIV LEICESTER·Filed 2003·Application pending·0 cites
- 2038US2006183174A1DiagnosisNG LEONG·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →